Chipotle, Bristol-Myers Squibb, Corteva And A Healthcare Giant On CNBC's 'Final Trades'

On CNBC’s "Halftime Report Final Trades," Brenda Vingiello of Sand Hill Global Advisors named CVS Health Corporation CVS as her final trade.

Analysts have a consensus Buy rating on CVS, according to Benzinga's analyst ratings data.

CVS Health reaffirmed its FY23 Outlook, seeing adjusted earnings of $8.50 to $8.70 per share.

Stephanie Link of Hightower picked Corteva, Inc. CTVA.

Corteva collaborated with the U.S. Agency for International Development (USAID) to aid farmers in Ukraine.

Don’t forget to check out our premarket coverage here

Jim Lebenthal of Cerity Partners named Bristol-Myers Squibb Company BMY as his final trade.

Bristol Myers Squibb released four-year follow-up data from the Phase 3 CheckMate -9LA trial to be presented in a late-breaking poster presentation at the 2023 American Society of Clinical Oncology (ASCO) annual meeting.

Joseph Terranova of Virtus Investment Partners picked Chipotle Mexican Grill, Inc. CMG.

Argus Research recently maintained Chipotle with a Buy and raised the price target from $2200 to $2400.

Price Action: Chipotle shares rose 0.6% to settle at $2,074.38, while Bristol-Myers Squibb shares rose 0.5% to close at $65.98 on Monday. Corteva shares rose 0.5% to close at $56.20, while CVS Health added 1.1% to $70.74 during Monday’s session.

Check This Out: HP, Alphabet And 2 Other Stocks Insiders Are Selling

Photo: Shutterstock